News & Blog

On July 9, 2025, Dr. Pallanti will speak at the Summer School on Affective Neuroscience on Mood, Aggression & Attraction with a lecture on "TMS for behavioral addiction.

Dr. Stefano Pallanti will participate in the CINP (The International College of Neuropsychopharmacology) Congress, specifically the 36th World Congress of Neuropsychopharmacology and the 9th Asian College of Neuropsychopharmacology Joint Congress. He will deliver a presentation titled "Precision Psychiatry CINP GNC Symposium: From Biomarker Discovery to Therapeutic Innovation Toward Personalized Mental Health Care."  The congress will take place in Melbourne, Australia, from June 15th to 18th, 2025.

Dr. Stefano Pallanti will participate in the conference as one of the leading experts on PANS/PANDAS and neuroinflammation and will give a presentation entitled "The Neuroinflammation Hypothesis in Psychiatry".  It will take place at the Palacongressi of the G. Martino University Hospital in Messina on 13 and 14 June 2025.

The Inflammatory Brain Disorders Conference features nationally and internationally renowned experts, including Dr. Stefano Pallanti, skilled in diagnostic and therapeutic approaches who will present a diverse range of emerging clinical and research challenges, insights, and advances in the field of inflammatory brain disorders. Presentations are carefully selected to familiarize attendees with rapidly developing research and to educate clinicians on the latest understanding of treatment options.

Since 2008, patients from all over Italy and Abroad have been using the service of online visits with Dr. Stefano Pallanti.
Don't let distance stop you from experiencing the neuroscientific approach and innovative treatments, backed by methods and tools validated by the latest scientific research.

Dr. Stefano Pallanti’s next visit to Casa di Cura La Madonnina in Milan will be on 27 February 2025.

Dr. Stefano Pallanti presented, as an expert in interventional psychiatry, a symposia entitled " Paradigm shift in neuromodulation for compulsive spectrum disorder" in Kobe, Japan on February 26, 2025 on the occasion of the 6th International Brain Stimulation Conference.

Dr. Stefano Pallanti’s next visit to Casa di Cura La Madonnina in Milan will be on 27 January 2025.

Dr. Pallanti communicates that this year, with the arrival of Influenza A, it is important to get vaccinated to prevent neurological sequelae.

Dr. Stefano Pallanti served as the Chairman of the symposium Obsessive compulsive disorder: new insights on biology and treatment.

This year, our scientific meeting will be held in-person in Milan, Italy, as well as virtually over Zoom. The meeting will be free for paid-up ICOCS and OCRN Members.

Transcranial Direct Current Stimulation (tDCS) is an innovative therapy that holds significant potential for improving the performance of professional soccer players, as highlighted by the recent scientific contribution of Dr. Stefano Pallanti.

Dr. Stefano Pallanti and Dr. Roberto Piga present the Manifesto against Sedentarism to fight the risks associated with physical inactivity, promoting healthy lifestyles and collective initiatives.

LET'S MEET! Let's invent something to do together against sedentarism!

On July 3, 2024, Dr. Pallanti delivered a lecture at the Summer School on Affective Neuroscience on the use of TMS in the personalized treatment of Obsessive-Compulsive Spectrum Disorders.

As a leading global expert on OCD, Dr. Stefano Pallanti gave lectures at the Training Masterclass on Obsessive-Compulsive Spectrum Disorders that took place from June 19th to 23rd, 2024 in Taormina, Sicily. He delivered two significant presentations focusing on PANDAS and the treatment of Obsessive-Compulsive Disorders.

A unique opportunity to expand your knowledge and experience in the field of Anxiety Disorders.

Dr. Stefano Pallanti took a lecture on Neuromodulation Therapies during the 4th module of the course.

On May 7th, 2024, Dr. Pallanti spoke at the 14th edition of the Masterclass in Pain Medicine organized by Advanced Algology Research in collaboration with the Quality of Life Foundation, offering an evening Talk entitled "Anti-neuro-inflammatory Effects of Psychoactive Drugs."

Discover the services offered by the new Neuroscience Point opened at the Fanfani Institute in Florence: Neuromodulation Therapies and Intravenous Infusion Therapy (IV Therapy) for the treatment of neuropsychiatric disorders, improving health and sports performance!

Dr. Stefano Pallanti was a speaker at the Neuromodulation Webinar organized by the Early Careers Committee of the International College of Neuropsychopharmacology (CINP), offering a presentation titled "TMS Basic Principles, Clinical Uses, and Research Principles: Toward Precision TMS."

The statement from Tesla and X CEO Elon Musk in a recent interview with Don Lemon, asserting that the use of the medication under medical prescription helps him alleviate negative mental states similar to Depression.

A recent study conducted by the Istituto di Neuroscienze and published in the prestigious International Journal of Mental Health and Addiction offers new hope for the treatment of addictions through an innovative therapy with Transcranial Magnetic Stimulation (TMS).

Dr. Stefano Pallanti was a speaker at the 3rd International Bioethics Conference organized by the University of Malta with a lecture entitled “Post-Covid Neuroscience and the Non-Mental Unconscious”.

Dr. Stefano Pallanti ― a leading international expert in the diagnosis and treatment of adult ADHD ― spoke at the General Meeting of the Swiss Society for ADHD. His intervention, entitled "Aging with ADHD," explored the challenges and characteristics of ADHD in adulthood and old age.

The third free course on Clinical Neuromodulation organized by the ECNP Neuromodulation Thematic Working Group focused on the application of neuromodulation techniques such as rTMS and Deep TMS in treating neuropsychiatric disorders according to a precision targeting and monitoring approach.

Published in World Psychiatry, the definition of "Treatment-Resistant Anxiety Disorder" given by leading researchers in the field aims to promote research into treatments that overcome resistance to traditional therapies. Dr. Pallanti is part of the multidisciplinary group of experts.

A group of the world’s leading researchers gathered for a Grand Round at the University of Cambridge to study new therapies for Pathological Gambling and other Behavioral Addictions.

Dr. Stefano Pallanti held a talk on the efficacy of Transcranial Magnetic Stimulation (TMS).

On November 22, 2023, Dr. Stefano Pallanti joined the "European Frontiers in Neuroscience" seminar series coordinated by Dr. Filippo Drago with a Grand Round regarding the topic "Behavioral Addictions: Prevention and Treatment."

On September 12 and 13 2023, Dr. Pallanti participated as an expert speaker in the fourth International Congress of the World Association for Anxiety and Related Stress Disorders (WASAD). His talks were on ADHD and PANDAS Syndrome.

Dr. Stefano Pallanti's Istituto di Neuroscienze has been appointed as the training site for the elective activities of the Massachusetts General Hospital, the teaching hospital of the Harvard Medical School.

A groundbreaking research by the Istituto di Neuroscienze in collaboration with Harvard University and funded by the National Institute of Health (NIH) paves the way for an innovative and effective treatment for pathological gambling.

Dr. Pallanti is a member of the "Mind4children" research group dedicated to the exploration of the origin of consciousness and the study of neurodevelopment in the early years of life.

On July 5, 2023, Dr. Pallanti spoke at the Summer School on Affective Neuroscience with a lecture on the use of TMS in the treatment of Behavioral Addictions.

On June 9, 2023, Dr. Pallanti lectured at the prestigious Universidad de La Laguna (Tenerife) on the topic of "From myths to neuroscience: obsessions as brain connectivity disorders, therapeutic goals and treatment with rTMS."

Discover all the services offered by the Neuroscience Center for Health located at the Zucchi Wellness Clinic in Monza (Italy): Neuromodulation Therapies to treat addictions and enhance Sports performance.

Understanding the factors that contribute to the development of Obsessive-Compulsive Disorder (OCD) is a crucial step in developing effective prevention and treatment strategies.

Learn more about the genetic and environmental risk factors associated with OCD.

A recent study has identified some specific biomarkers related to neuropsychiatric symptoms resulting from COVID-19 infection, providing an essential contribution to the diagnosis and treatment of Long COVID.

Read the results of the study!

Find out the possible adverse effects on the brain of concussions in Sports and what methods can be applied to prevent and reduce them.

Dr. Stefano Pallanti joined the Webinar organized by the Royal Society of Medicine as a panelist to address the topic "Neuromodulation in Psychiatry: Current Perspectives".

Aphasia is a language disorder that can have a very significant impact on people's ability to communicate. It is important to be able to diagnose and treat it as early as possible to increase the chances of recovery.

Scientific research has shown a potential connection between PANS-PANDAS and the gut microbiota, suggesting that streptococcal infections can alter intestinal bacterial communities, contributing to the onset of PANS-PANDAS symptoms.

Read this article to learn more.

Neurodevelopmental Disorders (NDs) are a broad and varied group of conditions that develop during childhood and adolescence and can persist throughout the entire life span.

Find out more about what they are and how to recognize them!

Psychiatric drugs are frequently the target of fear and prejudice, which may cause people to believe that they are harmful or that it is possible to become easily addicted to them.
On this page we analyze the main misconceptions related to these medications, providing accurate and up-to-date information.

Discover the Theta Burst Stimulation protocol: an innovative method of Transcranial Magnetic Stimulation approved by the FDA for treating Resistant Depression, used by Dr. Pallanti since 2016.

Discover Esketamine therapy for Treatment-Resistant Depression: a lifesaver for those who haven't responded to other treatments.

Discover the new Clinical Neuroscience Outpatient Clinic "Donatello Neuroscienze": an important new reality for the city of Florence and beyond.

Read more on this page!

Discover the services offered by our Neuroscience Point opened at the beautiful Villa Baruzziana facility: consultations and supervision by Dr. Stefano Pallanti and Neuromodulation Therapies.

An innovative technique showing promising results in the treatment of various disorders.

Learn more about Deep TMS provided by the Istituto di Neuroscienze!

TMS is a non-invasive neuromodulation technique increasingly used to treat a variety of neurological and psychiatric disorders.

Find out what TMS is, how it works, and what its applications are.

Learn more about the effects of the Sars-Cov-2 pandemic and which are the most common neurological and psychiatric manifestations through an interview of Dr. Pallanti.

The search for recovery is a common desire among those coping with a mental disorder. However, the treatment process goes beyond simply eliminating symptoms, and healing is made possible through a holistic approach to mental health.

Find out more in this article!

At the Istituto di Neuroscienze, we offer in-depth diagnostic pathways using advanced multidisciplinary diagnostic tools and personalized multimodal care derived from the latest neuroscience research data.

Learn more about our neuroscience-based Precision Diagnosis and Specialized Care pathway.

The purpose of treatment in psychiatry is the improvement of the quality and lengthening of life. The reduction or disappearance of symptoms is not enough.

Dr. Stefano Pallanti uses his notions of advanced clinical research to offer his patients the most innovative and effective therapies ever, around 20 years ahead of hospitals and clinics that rely on outdated guidelines for treatment choice.